Literature DB >> 25142104

Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass.

Aliye Uc1, Alicia K Olivier2, Michelle A Griffin1, David K Meyerholz2, Jianrong Yao1, Maisam Abu-El-Haija3, Katherine M Buchanan1, Oriana G Vanegas Calderón1, Marwa Abu-El-Haija4, Alejandro A Pezzulo5, Leah R Reznikov5, Mark J Hoegger5, Michael V Rector5, Lynda S Ostedgaard5, Peter J Taft5, Nick D Gansemer5, Paula S Ludwig5, Emma E Hornick5, David A Stoltz5, Katie L Ode1, Michael J Welsh, John F Engelhardt6, Andrew W Norris.   

Abstract

Diabetes is a common and significant co-morbidity in cystic fibrosis (CF). The pathogenesis of cystic fibrosis related diabetes (CFRD) is incompletely understood. Because exocrine pancreatic disease is similar between humans and pigs with CF, the CF pig model has the potential to contribute significantly to the understanding of CFRD pathogenesis. We determined the structure of the endocrine pancreas in fetal, newborn and older CF and non-CF pigs and assessed endocrine pancreas function by intravenous glucose tolerance test (IV-GTT). In fetal pigs, pancreatic insulin and glucagon density was similar between CF and non-CF. In newborn and older pigs, the insulin and glucagon density was unchanged between CF and non-CF per total pancreatic area, but increased per remnant lobular tissue in CF reflecting exocrine pancreatic loss. Although fasting glucose levels were not different between CF and non-CF newborns, CF newborns demonstrated impaired glucose tolerance and increased glucose area under the curve during IV-GTT. Second phase insulin secretion responsiveness was impaired in CF newborn pigs and significantly lower than that observed in non-CF newborns. Older CF pigs had elevated random blood glucose levels compared with non-CF. In summary, glycaemic abnormalities and insulin secretion defects were present in newborn CF pigs and spontaneous hyperglycaemia developed over time. Functional changes in CF pig pancreas were not associated with a decline in islet cell mass. Our results suggest that functional islet abnormalities, independent of structural islet loss, contribute to the early pathogenesis of CFRD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25142104      PMCID: PMC4346161          DOI: 10.1042/CS20140059

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  69 in total

1.  Pathology of cystic fibrosis review of the literature and comparison with 146 autopsied cases.

Authors:  E H Oppenheimer; J R Esterly
Journal:  Perspect Pediatr Pathol       Date:  1975

Review 2.  Gastrointestinal outcomes and confounders in cystic fibrosis.

Authors:  Drucy Borowitz; Peter R Durie; Lane L Clarke; Steven L Werlin; Christopher J Taylor; John Semler; Robert C De Lisle; Peter Lewindon; Steven M Lichtman; Maarten Sinaasappel; Robert D Baker; Susan S Baker; Henkjan J Verkade; Mark E Lowe; Virginia A Stallings; Morteza Janghorbani; Ross Butler; James Heubi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-09       Impact factor: 2.839

3.  Pathological confirmation of cystic fibrosis in the fetus following prenatal diagnosis.

Authors:  A Ornoy; J Arnon; D Katznelson; M Granat; B Caspi; J Chemke
Journal:  Am J Med Genet       Date:  1987-12

4.  Fine structure of islet-cell innervation in the pancreas of normal and alloxan-treated rats.

Authors:  S S Shorr; F E Bloom
Journal:  Z Zellforsch Mikrosk Anat       Date:  1970

5.  Pathology and pathogenesis of diseases of the pancreas.

Authors:  D S Longnecker
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307

6.  Relative underweight in cystic fibrosis and its prognostic value.

Authors:  R Kraemer; A Rüdeberg; B Hadorn; E Rossi
Journal:  Acta Paediatr Scand       Date:  1978-01

7.  Cystic fibrosis mortality and survival in the UK: 1947-2003.

Authors:  J A Dodge; P A Lewis; M Stanton; J Wilsher
Journal:  Eur Respir J       Date:  2006-12-20       Impact factor: 16.671

8.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

9.  Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.

Authors:  S Lanng; B Thorsteinsson; M E Røder; C Orskov; J J Holst; J Nerup; C Koch
Journal:  Acta Endocrinol (Copenh)       Date:  1993-03

10.  Mechanisms of glucose intolerance in cystic fibrosis.

Authors:  K Mohan; H Miller; P Dyce; R Grainger; R Hughes; J Vora; M Ledson; M Walshaw
Journal:  Diabet Med       Date:  2009-06       Impact factor: 4.359

View more
  36 in total

Review 1.  The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.

Authors:  Millie Garg; Chee Y Ooi
Journal:  Curr Gastroenterol Rep       Date:  2017-02

2.  Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.

Authors:  Yinghua Tang; Ziying Yan; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2020-04-15       Impact factor: 5.695

3.  Chronic Pancreatitis in the 21st Century - Research Challenges and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Authors:  Aliye Uc; Dana K Andersen; Melena D Bellin; Jason I Bruce; Asbjørn M Drewes; John F Engelhardt; Christopher E Forsmark; Markus M Lerch; Mark E Lowe; Brent A Neuschwander-Tetri; Stephen J OʼKeefe; Tonya M Palermo; Pankaj Pasricha; Ashok K Saluja; Vikesh K Singh; Eva M Szigethy; David C Whitcomb; Dhiraj Yadav; Darwin L Conwell
Journal:  Pancreas       Date:  2016-11       Impact factor: 3.327

4.  Pancreatic and Islet Remodeling in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Knockout Ferrets.

Authors:  Pavana G Rotti; Weiliang Xie; Ananta Poudel; Yaling Yi; Xingshen Sun; Scott R Tyler; Aliye Uc; Andrew W Norris; Manami Hara; John F Engelhardt; Katherine N Gibson-Corley
Journal:  Am J Pathol       Date:  2018-01-31       Impact factor: 4.307

Review 5.  Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer.

Authors:  Jami L Saloman; Kathryn M Albers; Zobeida Cruz-Monserrate; Brian M Davis; Mouad Edderkaoui; Guido Eibl; Ariel Y Epouhe; Jeremy Y Gedeon; Fred S Gorelick; Paul J Grippo; Guy E Groblewski; Sohail Z Husain; Keane K Y Lai; Stephen J Pandol; Aliye Uc; Li Wen; David C Whitcomb
Journal:  Pancreas       Date:  2019-07       Impact factor: 3.327

Review 6.  Cystic Fibrosis and the Nervous System.

Authors:  Leah R Reznikov
Journal:  Chest       Date:  2016-11-19       Impact factor: 9.410

Review 7.  Cystic fibrosis genetics: from molecular understanding to clinical application.

Authors:  Garry R Cutting
Journal:  Nat Rev Genet       Date:  2014-11-18       Impact factor: 53.242

Review 8.  The Clinical Biology of Cystic Fibrosis Transmembrane Regulator Protein: Its Role and Function in Extrapulmonary Disease.

Authors:  Theodore G Liou
Journal:  Chest       Date:  2018-10-22       Impact factor: 9.410

9.  Abnormal Glucose Tolerance in Infants and Young Children with Cystic Fibrosis.

Authors:  Yaling Yi; Andrew W Norris; Kai Wang; Xingshen Sun; Aliye Uc; Antoinette Moran; John F Engelhardt; Katie Larson Ode
Journal:  Am J Respir Crit Care Med       Date:  2016-10-15       Impact factor: 21.405

Review 10.  Endocrine Disorders in Cystic Fibrosis.

Authors:  Scott M Blackman; Vin Tangpricha
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.